ArticleAdvances in therapy2020

Economic Outcomes in Patients with Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate Plus Prednisone.

Krishnan Ramaswamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.